864 related articles for article (PubMed ID: 14984077)
21. Leukotriene receptor antagonists in the treatment of asthma: an update.
Balzano G; Fuschillo S; Gaudiosi C
Allergy; 2002; 57 Suppl 72():16-9. PubMed ID: 12144548
[TBL] [Abstract][Full Text] [Related]
22. A Comparison of Leukotriene Receptor Antagonists to Low-Dose Inhaled Corticosteroids in the Elderly with Mild Asthma.
Hong SH; Kang HR; Nam JH; Park SK; Kim TB; Lee EK
J Allergy Clin Immunol Pract; 2019; 7(8):2642-2652.e3. PubMed ID: 31108218
[TBL] [Abstract][Full Text] [Related]
23. Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma.
Pearlman DS; Stricker W; Weinstein S; Gross G; Chervinsky P; Woodring A; Prillaman B; Shah T
Ann Allergy Asthma Immunol; 1999 Mar; 82(3):257-65. PubMed ID: 10094216
[TBL] [Abstract][Full Text] [Related]
24. Inhaled corticosteroids or montelukast as the preferred primary long-term treatment for pediatric asthma?
Jartti T
Eur J Pediatr; 2008 Jul; 167(7):731-6. PubMed ID: 18214538
[TBL] [Abstract][Full Text] [Related]
25. Effects of inhaled corticosteroids, leukotriene receptor antagonists, or both, plus long-acting beta2-agonists on asthma pathophysiology: a review of the evidence.
Vignola AM
Drugs; 2003; 63 Suppl 2():35-51. PubMed ID: 14984079
[TBL] [Abstract][Full Text] [Related]
26. Characterization of within-subject responses to fluticasone and montelukast in childhood asthma.
Szefler SJ; Phillips BR; Martinez FD; Chinchilli VM; Lemanske RF; Strunk RC; Zeiger RS; Larsen G; Spahn JD; Bacharier LB; Bloomberg GR; Guilbert TW; Heldt G; Morgan WJ; Moss MH; Sorkness CA; Taussig LM
J Allergy Clin Immunol; 2005 Feb; 115(2):233-42. PubMed ID: 15696076
[TBL] [Abstract][Full Text] [Related]
27. Inhaled corticosteroid therapy with nebulized beclometasone dipropionate.
Nicolini G; Cremonesi G; Melani AS
Pulm Pharmacol Ther; 2010 Jun; 23(3):145-55. PubMed ID: 19961948
[TBL] [Abstract][Full Text] [Related]
28. Use of leukotriene receptor antagonists are associated with a similar risk of asthma exacerbations as inhaled corticosteroids.
Wu AC; Li L; Fung V; Kharbanda EO; Larkin EK; Vollmer WM; Butler MG; Miroshnik I; Rusinak D; Davis RL; Hartert T; Weiss ST; Lieu TA
J Allergy Clin Immunol Pract; 2014; 2(5):607-13. PubMed ID: 25213056
[TBL] [Abstract][Full Text] [Related]
29. Leukotriene-receptor antagonists versus placebo in the treatment of asthma in adults and adolescents: a systematic review and meta-analysis.
Miligkos M; Bannuru RR; Alkofide H; Kher SR; Schmid CH; Balk EM
Ann Intern Med; 2015 Nov; 163(10):756-67. PubMed ID: 26390230
[TBL] [Abstract][Full Text] [Related]
30. Comparison of leukotriene receptor antagonists in addition to inhaled corticosteroid and inhaled corticosteroid alone in the treatment of adolescents and adults with bronchial asthma: a meta-analysis.
Cao Y; Wang J; Bunjhoo H; Xie M; Xu Y; Fang H
Asian Pac J Allergy Immunol; 2012 Jun; 30(2):130-8. PubMed ID: 22830292
[TBL] [Abstract][Full Text] [Related]
31. Fluticasone propionate and salmeterol administered via Diskus compared with salmeterol or fluticasone propionate alone in patients suboptimally controlled with short-acting beta2-agonists.
Murray J; Rosenthal R; Somerville L; Blake K; House K; Baitinger L; VanderMeer A; Dorinsky P
Ann Allergy Asthma Immunol; 2004 Oct; 93(4):351-9. PubMed ID: 15521371
[TBL] [Abstract][Full Text] [Related]
32. Efficacy and safety of low-dose fluticasone propionate compared with montelukast for maintenance treatment of persistent asthma.
Meltzer EO; Lockey RF; Friedman BF; Kalberg C; Goode-Sellers S; Srebro S; Edwards L; Rickard K;
Mayo Clin Proc; 2002 May; 77(5):437-45. PubMed ID: 12004993
[TBL] [Abstract][Full Text] [Related]
33. Daily inhaled corticosteroids or montelukast for preschoolers with asthma or recurrent wheezing: A systematic review.
Castro-Rodriguez JA; Rodriguez-Martinez CE; Ducharme FM
Pediatr Pulmonol; 2018 Dec; 53(12):1670-1677. PubMed ID: 30394700
[TBL] [Abstract][Full Text] [Related]
34. Fluticasone propionate versus zafirlukast: effect in patients previously receiving inhaled corticosteroid therapy.
Kim KT; Ginchansky EJ; Friedman BF; Srebro S; Pepsin PJ; Edwards L; Stanford RH; Rickard K
Ann Allergy Asthma Immunol; 2000 Nov; 85(5):398-406. PubMed ID: 11101185
[TBL] [Abstract][Full Text] [Related]
35. A cost-effectiveness analysis of first-line controller therapies for persistent asthma.
Shih YC; Mauskopf J; Borker R
Pharmacoeconomics; 2007; 25(7):577-90. PubMed ID: 17610338
[TBL] [Abstract][Full Text] [Related]
36. Cost-efficacy analysis of fluticasone propionate versus zafirlukast in patients with persistent asthma.
Menendez R; Stanford RH; Edwards L; Kalberg C; Rickard K
Pharmacoeconomics; 2001; 19(8):865-74. PubMed ID: 11596838
[TBL] [Abstract][Full Text] [Related]
37. Predictors of asthma control and lung function responsiveness to step 3 therapy in children with uncontrolled asthma.
Rabinovitch N; Mauger DT; Reisdorph N; Covar R; Malka J; Lemanske RF; Morgan WJ; Guilbert TW; Zeiger RS; Bacharier LB; Szefler SJ
J Allergy Clin Immunol; 2014 Feb; 133(2):350-6. PubMed ID: 24084071
[TBL] [Abstract][Full Text] [Related]
38. Montelukast: a review of its therapeutic potential in persistent asthma.
Jarvis B; Markham A
Drugs; 2000 Apr; 59(4):891-928. PubMed ID: 10804041
[TBL] [Abstract][Full Text] [Related]
39. Comparative Effectiveness of Step-up Therapies in Children with Asthma Prescribed Inhaled Corticosteroids: A Historical Cohort Study.
Murray CS; Thomas M; Richardson K; Price DB; Turner SW
J Allergy Clin Immunol Pract; 2017; 5(4):1082-1090.e7. PubMed ID: 28351789
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
